TABLE 50 U.S. PATENTS GRANTED 135
TABLE 50 (CONTINUED) 136
TABLE 50 (CONTINUED) 137
TABLE 50 (CONTINUED) 138
TABLE 50 (CONTINUED) 139
TABLE 50 (CONTINUED) 140
TABLE 50 (CONTINUED) 141
TABLE 50 (CONTINUED) 142
Chapter-7: OUTLOOK: TRENDS AND CHALLENGES
GENERAL TRENDS 143
GENERAL TRENDS (CONTINUED) 144
ETHICAL IMPLICATIONS 145
ETHICAL IMPLICATIONS (CONTINUED) 146
Chapter-8: COMPANY PROFILES
ACADIA PHARMACEUTICALS 147
ACCERA, INC. 147
ACUMEN PHARMACEUTICALS 147
ALLON THERAPEUTICS (FKA NEURODISCOVERY) 147
ALZHYME PTY 148
AMARIN PHARMACEUTICALS 148
ASTRAZENECA 148
BRAINCELLS, INC. 149
COGNITION PHARMACEUTICALS 149
COLUCID PHARMACEUTICALS 149
COMENTIS 149
CORTEX PHARMACEUTICALS 150
ENVIVO PHARMACEUTICALS 150
GALENEA 150
GLAXOSMITH KLINE 151
HELICON THERAPEUTICS 151
INTELLECT NEUROSCIENCES 151
INTRA-CELLULAR THERAPIES 151
IPSEN 152
LEXICON PHARMACEUTICALS 152
MEDIVATION 152
MEMORY PHARMACEUTICALS 152
MERCK 153
MERCKSERONO 153
MITHRIDION 153
NEUREN PHARMACEUTICALS 153
NEUROSEARCH 153
NEURO-HITECH 154
NEWRON PHARMACEUTICALS 154
NOVARTIS 154
PFIZER 154
PRANA BIOTECHNOLOGY 155
PSYCHOGENICS 155
SANOFI-AVENTIS 155
SATORI PHARMACEUTICALS 155
SCIELE PHARMA 155
SEASIDE THERAPEUTICS 156
SHIRE 156
TAKEDA 156
TARGACEPT 156
TAURX THERAPEUTICS 156
TEVA PHARMACEUTICALS 157
VOYAGER PHARMACEUTICAL / DURAMED 157
WYETH 157
Chapter-9: APPENDIX
COMPANY LISTING 158
ACADIA PHARMACEUTICALS, INC. 158
ACCERA, INC. 158
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |